These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 224478)

  • 1. [Treatment of 100 acute myeloid leukemias (author's transl)].
    Fière D; Martin C; Vu Van H; Coiffier B; Felman P; Bryon PA; Favre-Gilly J; Revol L
    Sem Hop; 1979 Apr 8-15; 55(13-14):633-8. PubMed ID: 224478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and efficacy of 5-azacytidine used early in the therapy of adult acute nonlymphocytic leukemia: an ECOG pilot study.
    Cassileth PA; Petrillo MH; Cooper RA; Katz ME
    Cancer Clin Trials; 1979; 2(4):339-43. PubMed ID: 93983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
    Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute leukaemia during pregnancy: favourable course of pregnancy in two patients treated with cytosine arabinoside and anthracyclines (author's transl)].
    Colbert N; Najman A; Gorin NC; Blum F; Treisser A; Lasfargues G; Cloup M; Barrat H; Duhamel G
    Nouv Presse Med; 1980 Jan; 9(3):175-8. PubMed ID: 6928319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
    Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M
    Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM; Grañena A; Rozman C; Urbano-Ispizua A; Bladé J; Carreras E; Cervantes F; Marín P; Sierra J; Nomdedeu B
    Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study].
    Machover D; Schwarzenberg L; D'Hubert E; Lemaigre G; Caillou B; Tourani JM; Michalski B; Goldschmidt E; Gaget H; De Vassal F; Misset JL; Dorval T; Ribaud P; Jasmin C; Hayat M; Rappaport H; Mathé G
    Nouv Presse Med; 1982 Dec; 11(52):3835-9. PubMed ID: 6819542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PADOC therapy of aged patients with acute non-lymphocytic leukemia (author's transl)].
    Yoshikawa H
    Rinsho Ketsueki; 1978 Oct; 19(10):1351-6. PubMed ID: 283243
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
    Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
    Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemias.
    Fière D; Campos L; Van HV; Guyotat D; Archimbaud E; Extra JM; Coiffier B; Viala JJ; Bryon PA; Milan JJ
    Cancer Treat Rep; 1986 Feb; 70(2):285-6. PubMed ID: 3456272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute leukemias].
    Gross R; Gerecke D
    Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remission.
    Herve P; Rozenbaum A; Plouvier E; Flesch M; Cahn JY; Farradji A; Bergerat JP; Adjizian JC; Pignon B
    Cancer Treat Rep; 1982 Nov; 66(11):1983-5. PubMed ID: 6754076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.